51 JFK Parkway, Short Hills, NJ 07078
Tuesday, November 3, 2026

Insights & Analysis

Practical guidance on PBM audits, federal investigations, compounding defense, DEA enforcement, telehealth compliance, and the regulatory pressures facing pharmacies and providers nationwide.

More articles — Page 3

Page 3 of 110 · 995 articles
Mandatory Versus Permissive OIG Exclusion: What Triggers Each
Healthcare Fraud Defense

Mandatory Versus Permissive OIG Exclusion: What Triggers Each

Mandatory OIG exclusion follows automatically from certain convictions; permissive exclusion is OIG's discretionary call under a s…

Anthony MahajanNov 1, 2026
Wound Care Provider Compensation Arrangements: Product Use and Productivity Incentives
Wound Care

Wound Care Provider Compensation Arrangements: Product Use and Productivity Incentives

Wound care bonuses tied to product use or referral volume can trigger Anti-Kickback Statute and Stark Law exposure, not ordinary p…

Alison GoldmanOct 31, 2026
Telehealth and Pharmacy Referral Arrangements: Steering Risks
Telehealth Law

Telehealth and Pharmacy Referral Arrangements: Steering Risks

How routing prescriptions to one pharmacy exposes telehealth companies to Anti-Kickback Statute risk, and what OIG guidance says a…

Anthony MahajanOct 31, 2026
Responding to an OIG Subpoena in a Wound Care Investigation
Wound Care

Responding to an OIG Subpoena in a Wound Care Investigation

What an OIG subpoena requires, why skin substitute billing is under federal review, and how wound care practices preserve document…

Alison GoldmanOct 31, 2026
Reporting Practice Locations for Providers Who Deliver Telehealth From Home
Telehealth Law

Reporting Practice Locations for Providers Who Deliver Telehealth From Home

CMS permanently lets telehealth providers with an office skip the home address. Here is when it must appear on enrollment, and why…

Anthony MahajanOct 31, 2026
Credentialing and Hospital Privileges After Board Discipline: Answering the Questions
Healthcare Fraud Defense

Credentialing and Hospital Privileges After Board Discipline: Answering the Questions

Hospital, payer, and Medicare applications ask about prior board discipline, and NPDB queries verify the answer, with exposure for…

Anthony MahajanOct 31, 2026
California Board of Pharmacy Investigations, Citations and Fines
Healthcare Fraud Defense

California Board of Pharmacy Investigations, Citations and Fines

The California Board of Pharmacy investigates complaints, issues citations and fines, and refers serious violations to a formal ac…

Anthony MahajanOct 31, 2026
Reading an FCA Settlement Agreement: Covered Conduct and Releases
Healthcare Fraud Defense

Reading an FCA Settlement Agreement: Covered Conduct and Releases

A guide to how DOJ False Claims Act settlement agreements define Covered Conduct, scope the release, and reserve claims that survi…

Anthony MahajanOct 31, 2026
OIG Exclusion Release in FCA Settlements
Healthcare Fraud Defense

OIG Exclusion Release in FCA Settlements

OIG decides, separately from the DOJ settlement, whether to exclude a provider, demand a corporate integrity agreement, or release…

Anthony MahajanOct 31, 2026